NAEUN HOSPITAL
| Republic of Korea | Turkey | ||
| LDL Apheresis | - | from AUD $2,309 | from AUD $1,959 |
No hidden fees – just official clinic prices. Pay at the clinic for Hypertension treatment and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Hypertension treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Hypertension treatment journey.
Dr. Ahn Taehun is a cardiologist (MD, PhD) and Director of a Cardiovascular Center. He specializes in coronary artery disease, including angina and myocardial infarction. He also treats hypertension, heart valve disease, heart failure, and hyperlipidemia. His expertise includes interventional cardiology, echocardiography, and cardiovascular imaging. He also manages atherosclerosis, arterial occlusive disease, dilated cardiomyopathy, and myocarditis.
He has held several leadership roles. He served as Chairman of the Board of the Korean Society of Interventional Cardiology (KSIC) and President of the Korean Society of Cardiology (KSC). He was Finance Director of the KSC. He led the Korean Vascular Intervention Society (KVIS) and the Korean Cardiovascular Complications Committee (KCCC) as President. He also chaired the Organizing Committee for ENCORE SEOUL (Endovascular & Coronary Revascularization).
Dr. Min Jeong Kim is an interventional cardiologist at Incheon Sejong Hospital. She earned both her MD and PhD from Seoul National University College of Medicine. She specializes in heart failure, hypertension, and coronary artery disease treatment. Dr. Kim works at a KOIHA-accredited hospital that treats over 402,000 patients every year.
Dr. Byung Hee Oh is a cardiologist at Incheon Sejong Hospital. He previously served as President of the Korean Society of Cardiology. Dr. Oh specializes in heart failure, coronary artery disease, and complex arrhythmias. He held leadership roles at Seoul National University Hospital. Dr. Oh has authored hundreds of peer-reviewed publications. He treats patients at Sejong Hospital, which sees over 400,000 annual visits.
Dr. Oh Dongju, MD, PhD, is a cardiologist. He specializes in hypertension, hyperlipidemia, angina, myocardial infarction, valvular disease, dilated cardiomyopathy, and myocarditis. His work also covers atherosclerosis and arterial occlusive disease. He is skilled in echocardiography and cardiovascular imaging.
He completed a cardiology fellowship at Emory University School of Medicine. He also served as a Clinical Instructor at the Cornell University Weill Department of Medicine. He has held many leadership roles. He served as President, KSIC; Director of Publications, General Affairs, and Public Relations, KSC; Chairman, KACG; Board Member, Asan Heart Foundation; Vice President, KHA; Chairman, Division of Cardiology, KAIM; Vice President, NAMOK/KAMS; Governor, ACC Korea Chapter; and Member, the National Bioethics Committee.
South Korean care for hypertension focuses on proactive management. The general treatment threshold is 140/90 mmHg. High-risk cases, including those with diabetes or kidney disease, follow an intensive target below 130/80 mmHg. Medication typically involves Angiotensin Receptor Blockers (ARBs) and Calcium Channel Blockers (CCBs) alongside sodium reduction.
Bookimed Expert Insight: South Korea excels in cardiac diagnostics. Major facilities like Asan Medical Center serve 180,000+ patients yearly. A key advantage for international patients is the many specialists with overseas training. For instance, Prof. Oh Dong Joo worked at Cornell and Emory Universities. This helps protocols align with Korean and international cardiovascular standards.
Patient Consensus: Patients find that Korean care involves ongoing management and regular blood tests. Support services often include interpreters. This is vital for discussing long-term medication titration and home monitoring plans.
Hypertension medications in South Korea and Australia are equally effective. Both nations use the same internationally recognised drug classes including ARBs, CCBs, and diuretics. Success rates for blood pressure control in South Korea reach 70%. This matches top-performing Western nations like Australia and Canada.
Bookimed Expert Insight: Basic medications are standard globally, but South Korea's massive patient volumes create a data advantage. Asan Medical Center alone serves over 11,000 outpatients daily. This allows specialists to refine combination therapies rapidly across diverse patient profiles. They often reach high control rates sooner than in smaller clinical settings.
Patient Consensus: Patients note that focusing on active drug classes rather than brand names is vital. Bringing a current prescription list helps doctors in the Republic of Korea match or improve the existing treatment plan.
Hypertension treatment in South Korea typically requires long-term medication. Most patients continue treatment indefinitely to maintain stability. Korean specialists combine Western pharmaceuticals with lifestyle changes. This approach helps prevent cardiovascular disease. Diagnosis often includes 24-hour ambulatory monitoring. This allows for precise dosing during ongoing management.
Bookimed Expert Insight: South Korea is home to top-ranked digital hospitals like Seoul National University Bundang Hospital. These facilities use electronic systems to track data across millions of patients. This digitised approach is vital for Australians. It allows for seamless transfer of clinical records to GPs back home. This helps medication dosages remain consistent during interstate or international travel.
Patient Consensus: Patients note that treatment is a commitment to control rather than a permanent cure. They suggest checking if specific Korean drug brands are available in Australia before returning home.
South Korean doctors manage hypertension by prioritising less sodium and adopting DASH-style eating patterns. Specialists at major centres like Severance Hospital and Asan Medical Center emphasise whole grains. They also recommend plant-based proteins and fresh produce to lower blood pressure effectively.
Bookimed Expert Insight: Leading Korean cardiologists often share an academic background from Seoul National University. Dr Byung Hee Oh and Dr Min Jeong Kim both trained there before specialising in hypertension. This concentration of expertise means patients receive evidence-based care aligned with Korean Society of Cardiology standards.
Patient Consensus: Patients note that Korean doctors focus heavily on reducing salt in soups and stews. They find it helpful to ask for low-sodium swaps for traditional fermented side dishes.
Patients typically visit Korean clinics monthly while starting or adjusting blood pressure medication. Once blood pressure levels stabilise, appointments usually move to every 3 to 6 months. Major Seoul hospitals often use 24-hour monitoring and consultations to confirm long-term management plans quickly.
Bookimed Expert Insight: Major centres like Seoul National University Hospital serve millions of patients. However, hypertension management is often handled more efficiently at specialised cardiovascular centres. Asan Medical Center performs 45% of Korea's heart transplants and maintains heavy cardiology infrastructure. Patients with complex hypertension benefit from these high-volume centres. Specialists there manage thousands of cases, so medication protocols are optimised faster than at smaller clinics.
Patient Consensus: Patients in Korea find that initial visits are remarkably efficient. They note that repeat follow-ups are standard until blood pressure readings stabilise. Most advise bringing previous medical records and current lists of medications. This helps the doctor during these short, focused appointments.